You are being forwarded to your requested URL of https://www.finnegan.com/en/insights/blogs/ip-fda-blog/uspto-issues-memorandum-on-recent-subject-matter-eligibility-decision-vanda-pharm.-inc.-v.-west-ward-pharm..html?utm_source=mondaq&utm_medium=syndication&utm_content=sourceoriginal&utm_campaign=